Get the Stockscreener App
126.38
1.18%
-1.51
Davita Inc stock is traded at $126.38, with a volume of 686.69K.
It is down -1.18% in the last 24 hours and down -7.56% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$127.89
Open:
$128.59
24h Volume:
686.69K
Relative Volume:
0.87
Market Cap:
$9.04B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
11.77
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-4.33%
1M Performance:
-7.56%
6M Performance:
-17.32%
1Y Performance:
-20.67%
1-Day Range:
$126.31
$128.88
1-Week Range:
$126.31
$133.22
52-Week Range:
$126.07
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
126.38 | 9.14B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
418.87 | 99.74B | 72.70B | 6.88B | 7.29B | 23.81 |
|
THC
Tenet Healthcare Corp
|
194.85 | 17.71B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.16 | 15.89B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
123.16 | 12.53B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
201.60 | 13.06B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Can DaVita Inc. stock test all time highsWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
Barclays Maintains DaVita (DVA) Equal-Weight Recommendation - Nasdaq
Analyst Update: Barclays Lowers DaVita (DVA) Price Target | DVA Stock News - GuruFocus
Rep. Julie Johnson Sells Off Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
Outpatient & Specialty Care Stocks Q2 Highlights: DaVita (NYSE:DVA) - TradingView
What analysts say about DaVita Inc TRL stockStock Valuation Metrics & Invest Now – Opportunity Window Closing - earlytimes.in
DaVita partners with nonprofits for free health screenings across Los Angeles - CBS News
Barclays Adjusts Price Target on DaVita to $149 From $160 - MarketScreener
DaVita Inc. $DVA Shares Sold by Knights of Columbus Asset Advisors LLC - MarketBeat
DaVita (DVA) Valuation: Is the Recent Pullback an Opportunity for Investors? - Yahoo Finance
Has DaVita Inc. found a price floorMarket Performance Report & AI Based Trade Execution Alerts - newser.com
Robeco Institutional Asset Management B.V. Has $6.38 Million Stake in DaVita Inc. $DVA - MarketBeat
Will DaVita Inc. stock recover faster than peersEarnings Risk Report & Weekly Watchlist for Consistent Profits - newser.com
Is DaVita Stock Underperforming the Nasdaq? - MSN
Will DaVita Inc. stock remain on Wall Street radarJuly 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Is DaVita Inc. stock positioned for secular growthEarnings Beat & Technical Pattern Alert System - newser.com
J. Safra Sarasin Holding AG Lowers Stock Holdings in DaVita Inc. $DVA - MarketBeat
Why DaVita Inc. stock could benefit from AI revolution2025 Big Picture & Low Risk Entry Point Tips - newser.com
DaVita Inc. (NYSE:DVA) Given Average Rating of "Reduce" by Analysts - MarketBeat
DaVita HealthCare (DVA) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Can a trend reversal in DaVita Inc. lead to recoveryQuarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
Public Employees Retirement System of Ohio Sells 2,903 Shares of DaVita Inc. $DVA - MarketBeat
Is DaVita Inc. stock attractive for long term wealth buildingQuarterly Profit Report & Free Technical Pattern Based Buy Signals - newser.com
Will DaVita Inc. stock hit analyst forecasts2025 Performance Recap & Real-Time Volume Analysis - newser.com
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts - MSN
TD Private Client Wealth LLC Cuts Position in DaVita Inc. $DVA - MarketBeat
What drives DaVita Inc stock priceOptions Trading Strategies & Maximize ROI With Proven Growth Stocks - earlytimes.in
DaVita shares slide nearly 7% as 2025 outlook disappoints - MSN
DaVita Inc TRL Stock Analysis and ForecastWeekly Market Snapshot & Manage Volatility With Calm, Data-Backed Moves - earlytimes.in
DaVita Inc. (DVA) Stock Analysis: Evaluating A 17.35% Upside In The Healthcare Sector - DirectorsTalk Interviews
DaVita Inc. (DVA) Stock Analysis: Insights into Potential 17.35% Upside for Healthcare Investors - DirectorsTalk Interviews
Assenagon Asset Management S.A. Cuts Stake in DaVita Inc. $DVA - MarketBeat
Is DaVita Inc. (TRL) stock suitable for passive index fundsMarket Performance Report & Technical Pattern Recognition Alerts - newser.com
DaVita Inc. $DVA Shares Sold by Patton Fund Management Inc. - MarketBeat
Is DaVita Inc a good long term investmentSupport Level Holds & Access Powerful Market Insights - earlytimes.in
DaVita partners with nonprofits for free health screenings across Los Angeles. Here's how to sign up - CBS News
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):